Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 11/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | MAPK13 | O15264 | 2/20 | 0.39 |
| ▸ | MAPK12 | P53778 | 2/20 | 0.39 |
| ▸ | MAPK11 | Q15759 | 2/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17084351 | 0.93 | ALDH1A1 (0.42) | PDK2ALDH1A1HTTAPEX1MAPK13 | |
| SCHEMBL21025504 | 0.88 | ALDH1A1 (0.44) | PDK2ALDH1A1HTTAPEX1MAPK13 | |
| SCHEMBL28635928 | 0.86 | PDK2 (0.39) | PDK2APEX1CNR2 | |
| SCHEMBL17084352 | 0.84 | PDK2 (0.42) | PDK2ALDH1A1HTTMAPK13MAPK12 | |
| SCHEMBL30266914 | 0.84 | PDK2 (0.42) | PDK2ALDH1A1HTTMAPK13MAPK12 | |
| SCHEMBL17084309 | 0.84 | ALDH1A1 (0.36) | PDK2ALDH1A1HTTMAPK13MAPK12 | |
| SCHEMBL21025031 | 0.83 | ALDH1A1 (0.47) | PDK2ALDH1A1HTTMAPK13MAPK12 | |
| SCHEMBL21183152 | 0.83 | NAAA (0.38) | PDK2ALDH1A1HTTMAPK13MAPK12 | |
| SCHEMBL21024709 | 0.83 | ALDH1A1 (0.41) | ALDH1A1HTT | |
| SCHEMBL16477967 | 0.83 | CNR2 (0.39) | ALDH1A1HTTMAPK13MAPK12MAPK11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10995082-B2 | Cationic photoinitiator and preparation method and use thereof | CHANGZHOU TRONLY NEW ELECTRONIC MATERIALS CO., LTD. (CN) | 2021-05-04 | — | — | US | disclosed |
| US-20190218199-A1 | NOVEL CATIONIC PHOTOINITIATOR AND PREPARATION METHOD AND USE THEREOF | CHANGZHOU TRONLY ADVANCED ELECTRONIC MATERIALS CO., LTD. (CN) | 2019-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10995082-B2 | Cationic photoinitiator and preparation method and use thereof | SLC11A2, SLC7A1, PPOX | PDK2 1523/4885ALDH1A1 3153/4885HTT 1956/4885 |
| US-20190218199-A1 | NOVEL CATIONIC PHOTOINITIATOR AND PREPARATION METHOD AND USE THEREOF | SLC11A2, SLC7A1, PPOX | PDK2 1368/4885ALDH1A1 2798/4885HTT 2128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.